Henry Schein, Vir Biotechnology, Ultra Clean Holdings And Other Big Stocks Moving Higher On Tuesday
U.S. stocks saw broad gains on Tuesday, with the Dow Jones index rising, driven by strong quarterly results from several companies. Henry Schein (NASDAQ:HSIC) jumped over 8% after beating analyst estimates for earnings and sales. Other significant movers included Palvella Therapeutics (NASDAQ:PVLA), Vir Biotechnology (NASDAQ:VIR), Iovance Biotherapeutics (NASDAQ:IOVA), Clarivate Plc (NYSE:CLVT), and Keysight Technologies (NYSE:KEYS), all reporting strong financial performance or positive clinical trial data, leading to substantial stock price increases.
DEC 23·MarketBeat→
Iovance Biotherapeutics (NASDAQ:IOVA) Trading Up 8.7% - Still a Buy?
Iovance Biotherapeutics (NASDAQ:IOVA) saw its shares rise by 8.7% on Monday, closing at $2.6950 with a significant drop in trading volume. Despite this surge, analysts are divided on the company's prospects, with a consensus "Hold" rating and an average price target of $11.10. The clinical-stage biotech, which focuses on tumor-infiltrating lymphocyte (TIL) therapies, continues to report negative earnings and margins while institutional investors have been actively adjusting their positions.
NOV 27·Motley Fool→
Iovance ( IOVA ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Nov. 6, 2025 at 3:16 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
